# FDA Inspection 1083817 - ImpactLife - March 12, 2019

Source: https://www.keypedia.com/records/fda_inspections/impactlife/939d2353-08ae-47e0-9ebb-5376d6c847fe
Source feed: FDA_Inspections

> FDA Inspection 1083817 for ImpactLife on March 12, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1083817
- Company Name: ImpactLife
- Inspection Date: 2019-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1298962 - 2026-01-15](https://www.keypedia.com/records/fda_inspections/impactlife/789a3503-7fd6-4998-a15a-5c5eef11f84e)
- [FDA Inspection 1298962 - 2026-01-15](https://www.keypedia.com/records/fda_inspections/impactlife/85c51ea7-7c22-4353-8802-1e551063538d)
- [FDA Inspection 1205661 - 2023-05-17](https://www.keypedia.com/records/fda_inspections/impactlife/837f6fb2-9804-41c4-90bd-10ed8f9d6269)
- [FDA Inspection 1205661 - 2023-05-17](https://www.keypedia.com/records/fda_inspections/impactlife/77b5b1d0-3e87-45b2-8023-29704634cbeb)
- [FDA Inspection 995153 - 2016-12-05](https://www.keypedia.com/records/fda_inspections/impactlife/c2328ead-1a65-42b8-924d-bf702f59900a)

Company: https://www.keypedia.com/companies/impactlife/3bb2142f-a0d8-4014-8859-0f420b02bc4b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d